• Nivestim 48 MU/0.5 ml solution for injection or for infusion

  Form: solution for injection and infusion in pre-filled syringe

  Active substance	Dosage
  FILGRASTIM	48 MILLONES UI

  ATC: L03A L03AA L03AA02

• Paxlovid 150 mg + 100 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  NIRMATRELVIR	150 mg
  RITONAVIR	100 mg

  ATC: J05A J05AE J05AE30

• Prevenar 13 injectable suspension

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 14	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 18C	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 19A	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 19F	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 23F	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 3	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 1	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 4	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 6B	4,4 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 9V	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 5	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 7F	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 6A	2,2 µg

  ATC: J07A J07AL J07AL02

• Prevenar 13 injectable suspension

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 14	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 18C	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 19A	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 19F	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 23F	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 3	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 1	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 4	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 6B	4,4 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 9V	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 5	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 7F	2,2 µg
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 6A	2,2 µg

  ATC: J07A J07AL J07AL02

• Prevenar 20 injectable suspension in pre-filled syringe

  Form: suspension for injection

  Active substance	Dosage
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 1	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 3	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 4	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 5	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 6A	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 7F	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 8	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 9V	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 10A	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 11A	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 12F	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 14	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 15B	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 18C	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 19A	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 19F	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 22F	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 23F	4,4 microgramos/ml
  PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE ANTIGEN SEROTYPE 33F	4,4 microgramos/ml

  ATC: J07A J07AL J07AL02

• Rapamune 0.5 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SIROLIMUS	0,5 mg

  ATC: L04A L04AH L04AH01

• Rapamune 1 mg coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SIROLIMUS	1 mg

  ATC: L04A L04AH L04AH01

• Rapamune 1 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  SIROLIMUS	1 mg

  ATC: L04A L04AH L04AH01

• Rapamune 2 mg coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SIROLIMUS	2 mg

  ATC: L04A L04AH L04AH01

• Refacto AF 1000 IU powder and solvent for solution for injection in pre-filled syringe

  Form: powder and solvent for solution for injection in pre-filled syringe

  Active substance	Dosage
  MOROCTOCOG ALFA	1000 UI

  ATC: B02B B02BD B02BD02

• Refacto AF 2000 IU powder and solvent for solution for injection in pre-filled syringe

  Form: powder and solvent for solution for injection in pre-filled syringe

  Active substance	Dosage
  MOROCTOCOG ALFA	2000 UI

  ATC: B02B B02BD B02BD02

• Refacto AF 250 IU powder and solvent for solution for injection in pre-filled syringe

  Form: powder and solvent for solution for injection in pre-filled syringe

  Active substance	Dosage
  MOROCTOCOG ALFA	250 UI

  ATC: B02B B02BD B02BD02

• Refacto AF 3000 IU powder and solvent for solution for injection in pre-filled syringe

  Form: powder and solvent for solution for injection in pre-filled syringe

  Active substance	Dosage
  MOROCTOCOG ALFA	3000 UI

  ATC: B02B B02BD B02BD02

• Refacto AF 500 IU powder and solvent for solution for injection in pre-filled syringe

  Form: powder and solvent for solution for injection in pre-filled syringe

  Active substance	Dosage
  MOROCTOCOG ALFA	500 UI

  ATC: B02B B02BD B02BD02

• Retacrit 1000 IU/0.3 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	1000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 10000 IU/1.0 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	10000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 2000 IU/0.6 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	2000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 20000 IU/0.5 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	20000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 3000 IU/0.9 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	3000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 30000 IU/0.75 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	30000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 4000 IU/0.4 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	4000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 40000 IU/1.0 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	40000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 5000 IU/0.5 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	5000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 6000 IU/0.6 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	6000 UI

  ATC: B03X B03XA B03XA01

• Retacrit 8000 IU/0.8 ml solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  EPOETIN ZETA	8000 UI

  ATC: B03X B03XA B03XA01

• Ruxience 100 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  RITUXIMAB	Igual a 10 mg mg

  ATC: L01F L01FA L01FA01

• Ruxience 500 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  RITUXIMAB	500 mg

  ATC: L01F L01FA L01FA01

• Somavert 10 mg powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  PEGVISOMANT	10 mg

  ATC: H01A H01AX H01AX01

• Somavert 15 mg powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  PEGVISOMANT	15 mg

  ATC: H01A H01AX H01AX01

• Somavert 20 mg powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  PEGVISOMANT	20 mg

  ATC: H01A H01AX H01AX01

• Somavert 25 mg powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  PEGVISOMANT	25 mg

  ATC: H01A H01AX H01AX01

• Somavert 30 mg powder and solvent for solution for injection

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  PEGVISOMANT	30 mg

  ATC: H01A H01AX H01AX01

• Sutent 12.5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  SUNITINIB	12,5 mg

  ATC: L01E L01EX L01EX01

• Sutent 25 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  SUNITINIB	25 mg

  ATC: L01E L01EX L01EX01

• Sutent 50 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  SUNITINIB	50 mg

  ATC: L01E L01EX L01EX01

• Talzenna 0.1 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  TALAZOPARIB TOSILATE	0,145 mg

  ATC: L01X L01XK L01XK04

• Talzenna 0.25 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  TALAZOPARIB TOSILATE	0.363 mg

  ATC: L01X L01XK L01XK04

• Topotecan Hospira 4 mg/4 ml concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  TOPOTECAN HYDROCHLORIDE	1 mg

  ATC: L01C L01CE L01CE01

• Torisel 30 mg concentrate and solvent for solution for infusion

  Form: solution for infusion, concentrate and solvent

  Active substance	Dosage
  TEMsirolimus	25 mg

  ATC: L01E L01EG L01EG01

• Toviaz 4 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  FESOTERODINE FUMARATE	4 mg

  ATC: G04B G04BD G04BD11

• Toviaz 8 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  FESOTERODINE FUMARATE	8 mg

  ATC: G04B G04BD G04BD11

• Trazimera 150 mg powder for concentrate for infusion solution

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  TRASTUZUMAB	150 mg

  ATC: L01F L01FD L01FD01

• Trazimera 420 mg powder for concentrate for solution for infusion

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  TRASTUZUMAB	420 mg

  ATC: L01F L01FD L01FD01

• Trumenba injectable suspension in pre-filled syringe

  Form: suspension for injection

  Active substance	Dosage
  RECOMBINANT FHBP LIPOPROTEIN FROM NEISSERIA MENINGITIDIS SEROGROUP B RL2086 SUBFAMILY A	120 µg
  RECOMBINANT FHBP LIPOPROTEIN FROM NEISSERIA MENINGITIDIS SEROGROUP B RL2086 SUBFAMILY B	120 µg

  ATC: J07A J07AH J07AH09

• Tukysa 150 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TUCATINIB HEMI-ETHANOLATE	157,2 mg

  ATC: L01E L01EH L01EH03

• Tukysa 50 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  TUCATINIB HEMI-ETHANOLATE	52,4 mg

  ATC: L01E L01EH L01EH03

• Tygacil 50 mg powder for solution for infusion

  Form: powder for solution for infusion

  Active substance	Dosage
  TIGECYCLINE	50 mg

  ATC: J01A J01AA J01AA12

• VYDURA 75 mg oral lyophilisate

  Form: powder for preparation of oral solution

  Active substance	Dosage
  RIMEGEPANT SULFATE	85,65 mg

  ATC: N02C N02CD N02CD06

• VYNDIQEL 20 mg soft capsules

  Form: capsules, soft gelatin

  Active substance	Dosage
  TAFAMIDIS MEGLUMINE	20 mg

  ATC: N07X N07XX N07XX08

• Velsipity 2 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ETRASIMOD L-ARGININE	2,762 mg

  ATC: L04A L04AE L04AE05